Posts by month
February 2020
A step forward in prostate cancer screening optimisation
A single prostate-specific antigen (PSA) measurement in midlife may help to personalise prostate cancer screening, resulting in a reduced risk of overdiagnosis and overtreatment of indolent cancers. The authors of…
Chiara Gasparotto – winning the case for better access to radiotherapy
A quarter of cancer patients who could benefit from radiotherapy do not receive it. As head of policy and partnerships, Chiara Gasparotto is positioning the European Society for Radiotherapy to…
AI will help Cinderella to see herself in the mirror
Many women who undergo breast reconstruction after mastectomy end up disappointed. It is estimated that as many as 30% of women have to live with aesthetic results they are not…
UNESCO pledges to end the gender imbalance in science
Science and gender equality are both vital for the achievement of the internationally agreed development goals, including the 2030 Agenda for Sustainable Development. Over the past 15 years, the global…
New evidence shows effectiveness of a single-dose of HPV vaccine
To prevent pre-invasive cervical disease, a single dose of the human papillomavirus (HPV) vaccine could be enough. Investigation of more than 130,000 young women suggests that 1 dose of quadrivalent…
The unique toxicities of CAR-T cell therapy
The advent of chimeric antigen receptor T cell (CAR T cell) therapy generated great excitement in the field of onco-haematology. Clinical trials have shown remarkable results in patients with…
Everyone is invited to help with the EU Beat Cancer Plan
Today, on World Cancer Day, the European Commission president Ursula von der Leyen announced the launch of a EU-wide public consultation on the forthcoming “Beating Cancer Plan”, which aims to…
Tackling cancer in interesting times
Being Venetian by birth, I am a keen visitor to the Biennale – the contemporary art exhibition that is hosted by the city every two years. In 2019, reflecting this…
Non-cancer drugs repurposing, a new trick to win the onco-challenge?
Originally developed and approved for use in diabetes, inflammation and other non-oncological diseases (even osteoarthritis in dogs), many drugs could have a pivotal role in treating cancer. And they could…